These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 30540657

  • 21. The MARLINA-T2D trial: putting the results into clinical perspective.
    Lajara R.
    Expert Rev Endocrinol Metab; 2018 May; 13(3):173-176. PubMed ID: 30058901
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients.
    Heise T, Graefe-Mody EU, Hüttner S, Ring A, Trommeshauser D, Dugi KA.
    Diabetes Obes Metab; 2009 Aug; 11(8):786-94. PubMed ID: 19476474
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy.
    Pathak JV, Dass EE.
    Indian J Pharmacol; 2015 Aug; 47(2):148-52. PubMed ID: 25878372
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evaluation of Risk of Bullous Pemphigoid With Initiation of Dipeptidyl Peptidase-4 Inhibitor vs Second-generation Sulfonylurea.
    Lee H, Chung HJ, Pawar A, Patorno E, Kim DH.
    JAMA Dermatol; 2020 Oct 01; 156(10):1107-1114. PubMed ID: 32697283
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Linagliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes.
    Tiwari A.
    Curr Opin Investig Drugs; 2009 Oct 01; 10(10):1091-104. PubMed ID: 19777398
    [Abstract] [Full Text] [Related]

  • 34. Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.
    Rossing K, Jacobsen P, Pietraszek L, Parving HH.
    Diabetes Care; 2003 Aug 01; 26(8):2268-74. PubMed ID: 12882847
    [Abstract] [Full Text] [Related]

  • 35. Dipeptidyl peptidase-4 inhibitors and cardiovascular and renal disease in type 2 diabetes: What have we learned from the CARMELINA trial?
    Hanssen NM, Jandeleit-Dahm KA.
    Diab Vasc Dis Res; 2019 Jul 01; 16(4):303-309. PubMed ID: 31018682
    [Abstract] [Full Text] [Related]

  • 36. Comparative effectiveness of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers in patients with type 2 diabetes and retinopathy.
    Shih CJ, Chen HT, Kuo SC, Li SY, Lai PH, Chen SC, Ou SM, Chen YT.
    CMAJ; 2016 May 17; 188(8):E148-E157. PubMed ID: 27001739
    [Abstract] [Full Text] [Related]

  • 37. The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through 'stacking' of drugs from different classes.
    Bell DSH, Jerkins T.
    Diabetes Obes Metab; 2024 Jun 17; 26(6):2046-2053. PubMed ID: 38516874
    [Abstract] [Full Text] [Related]

  • 38. Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid, likely triggered by scabies, in a hemodialysis patient with human leukocyte antigen-DQB1*03:01.
    Hibi A, Kasahara Y, Ishihara Y, Hata K, Hosokawa N, Nakagawa T.
    CEN Case Rep; 2020 Aug 17; 9(3):189-194. PubMed ID: 31993957
    [Abstract] [Full Text] [Related]

  • 39. Linagliptin monotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator-controlled, double-blind study.
    Kawamori R, Inagaki N, Araki E, Watada H, Hayashi N, Horie Y, Sarashina A, Gong Y, von Eynatten M, Woerle HJ, Dugi KA.
    Diabetes Obes Metab; 2012 Apr 17; 14(4):348-57. PubMed ID: 22145698
    [Abstract] [Full Text] [Related]

  • 40. Effects of telmisartan and linagliptin when used in combination on blood pressure and oxidative stress in rats with 2-kidney-1-clip hypertension.
    Chaykovska L, Alter ML, von Websky K, Hohmann M, Tsuprykov O, Reichetzeder C, Kutil B, Kraft R, Klein T, Hocher B.
    J Hypertens; 2013 Nov 17; 31(11):2290-8; discussion 2299. PubMed ID: 24077249
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.